OneSource Reports INR 47 Crore Net Loss in Q3 FY26 as Revenue Falls 26 Percent
OneSource Specialty Pharma reported a weak performance in the third quarter of FY26, posting a net loss of INR 47 crore for the quarter ended December 31, 2025. The company’s revenue declined 26 percent year on year to INR 290 crore, largely due to delays in converting a key service agreement into a commercial supply contract.
Revenue Falls 26 Percent | 27/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy